|
Abstract: . . . contributor to the initiation and progression of atherosclerotic disease. Aspirin and Plavix are the most widely used antiplatelet drugs (widely used . . . . . . David Phillips, is in Australia today to discuss how new drug development can help win the war against heart disease. Cardiovascular disease (CVD) . . . . . . San Francisco, wants to develop more effective antiplatelet drugs to prevent and treat acute and chronic thrombosis . In addition, he is proposing . . . . . . will be discussing future directions for antithrombotic drug development and the limitations of current drugs. . . . --608,4,76,875,3038
|